Body Changes

Skin, hair, oral, and vulvovaginal changes are part of the perimenopause and postmenopause experience — and they are commonly underrecognized. In one clinic survey, nearly half of women had self-managed skin symptoms without medical guidance before connecting them to the menopausal transition. The patient-facing value of this section is validation and recognition, not a treatment menu.

An important caveat about the numbers in this section: Much of the symptom-frequency data below comes from a single specialist menopause-clinic survey (58) of 50 women, 77% of whom were already on hormonal treatment, at a private clinic. These are recognition-within-a-selected-sample figures — they tell you these symptoms are commonly reported among women who seek specialist menopause care, not that they affect all menopausal women at these rates.

Skin

Hair

In the same survey, 82% reported at least one hair symptom — thinning in 54%, shedding in 44%. These are linked to estrogen decline and relative androgen dominance. Pattern hair-loss severity correlates with menopausal status in the cited literature.

A specific pattern — frontal fibrosing alopecia (FFA) — is a scarring-type hair loss with autoimmune features. In cited studies, FFA onset was postmenopausal in 93-100% of cases. The dermatology review treats this pattern as dermatology assessment territory rather than standard menopause care. Off-label oral hair-loss medications referenced in the review (minoxidil, spironolactone, finasteride/dutasteride) are not supported by menopause-specific evidence (113, 58).

Collagen Supplementation

Oral and Vulvovaginal Symptoms

In the same specialist clinic survey, 58% reported at least one oral symptom and 36% reported dry mouth. Vulval symptoms were even more common: 84% reported at least one, with dryness at 58%, itchiness at 54%, and soreness at 38%.

Oral symptoms are easy to lose in the menopause conversation. The evidence suggests that oral changes during perimenopause may benefit from dental or oral medicine assessment, but menopause-specific oral-symptom trials are limited. Vulvovaginal symptoms are addressed in detail in the Genitourinary Health section, where vaginal estrogen, DHEA, and ospemifene are discussed per ICSM 2024 guidance (58).

Body Image

Dry Eyes

Dry-eye symptoms are addressed in the What to Watch For section. In brief: 64.9% of midlife women in a Thai gynaecology/menopause clinic (n=262) had OSDI-defined dry-eye symptoms, with computer-based work as the only independent multivariate predictor of moderate-to-severe symptoms. HRT users were excluded from that study, and the broader literature on HRT and dry eye is inconsistent (82).

Questions to Bring to Your Doctor

• "I've noticed [skin/hair/oral/vulval] changes that started around the time my periods became irregular. Could these be related to perimenopause?"
• "I had a pre-existing skin condition that has gotten worse. Is that consistent with what the research shows during the transition?"
• "My hair is thinning in a pattern along my hairline. Is that the kind of pattern that the dermatology literature treats differently?"
• "I have dry mouth and oral changes. Is there guidance on whether this needs dental assessment during perimenopause?"